References
- Fifth Report of the Joint National Committee on Detection,Evaluation and Treatment of High Blood Pressure (JNC V). Arch. Int. Med (1993) 153:154–182.
- SEVER P, BEEVERS G, BULPITT C, ET AL.: Managementguidelines in essential hypertension; report of the second working party of the British Hypertension So-ciety. Br. Med. J. (1993) 306:983–907.
- GUIDELINES SUB-COMMIT IEE: Guidelines for the treat-ment of mild hypertension: memorandum from a World Health Organisation/ International Society of Hypertension meeting. J. Hypertens. (1993) 11:905–918.
- CARRUTHERS SG, LA ROCHELLE P, HAYNES RB ET AL.: Report of a Canadian Hypertension Society consensus conference. 1. Introduction. Canad. Med. Ass. J. (1993) 149: 289–293.
- JACKSON R, BARHAM P, BILLS J, ET AL.: Management ofraised blood pressure in New Zealand: a discussion document Br. Med. .1 (1993) 307:107-110.
- THE CONSENSUS PANEL (Australian Consensus Confer-ence): The management of hypertension; a consensus statement Med. J. Aust. In press.
- ROBERTSON JIS: Guidelines for the treatment of hyper-tension; a critical review. Cardiovasc. Drugs Tberap. In press.
- CHALMERS JP: The National Consensus Conference: not always what it seems. Blood Pressure (1994) 3:4–6.
- ROBERTSON JIS: Should the costs of development in-hibit research into new antihypertensive drugs? Cardiovasc. Drugs Tberap. (1989) 3:757–759.
- FOLKOW B, HANSSON L, SNERTSSON R: Structural vas-cular factors in the pathogenesis of hypertension. In: Hypertension. Robertson JIS (Ed), Elservier, Amsterdam, 1983 p133-15o.
- ROBERTSON JIS, NICHOLLS MG (Eds): The Renin-Angioten-sin System. Gower,. London/New York, 1993.
- BRUNNER HR, NUSSBERGER J, WAEBER B: Angiotensin antagonists. 1131D Vol. 2p86.1–86.14.
- HUT KY, HABER E: Renin inhibitors. IBID Vol. 2 p85.1-85.14.
- FLETCHER AE, DOLLERY CT: Side effects associated with Inhibitors of angiotensin-converting enzyme. IBID Vol. 2 p99.1-99.15.
- CATT KJ: Angiotensin receptors. IBID Vol. 1 p12.1-12.14.
- RICHARDS AM, NICHOLLS MG: Inter-relations between renin and atrial natriuretic factor. IBID Vol. 1 p36.1-36.17.